Design
Review
Authors
Loading...
Positions RyR2 as therapeutic target in HF and inherited arrhythmias; leaves open whether modulation improves patient outcomes.
Key points are not available for this paper at this time.
Mark Scoote (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: